Details for New Drug Application (NDA): 020762
✉ Email this page to a colleague
The generic ingredient in NASONEX is mometasone furoate. There are thirty drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.
Summary for 020762
Tradename: | NASONEX |
Applicant: | Organon Llc |
Ingredient: | mometasone furoate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020762
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SPRAY, METERED;NASAL | Strength | 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Oct 1, 1997 | TE: | RLD: | Yes |
Expired US Patents for NDA 020762
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Organon Llc | NASONEX | mometasone furoate | SPRAY, METERED;NASAL | 020762-001 | Oct 1, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Organon Llc | NASONEX | mometasone furoate | SPRAY, METERED;NASAL | 020762-001 | Oct 1, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Organon Llc | NASONEX | mometasone furoate | SPRAY, METERED;NASAL | 020762-001 | Oct 1, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription